Deferred Tax Assets, Net of Valuation Allowance in USD of AGILE THERAPEUTICS INC from Q4 2016 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary
Agile Therapeutics Inc quarterly Deferred Tax Assets, Net of Valuation Allowance history and change rate from Q4 2016 to Q4 2023.
  • Agile Therapeutics Inc Deferred Tax Assets, Net of Valuation Allowance for the quarter ending 31 Dec 2023 was $0.000.
Deferred Tax Assets, Net of Valuation Allowance, Quarterly (USD)

AGILE THERAPEUTICS INC Quarterly Deferred Tax Assets, Net of Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed
Q4 2023 $0 $0 31 Dec 2023 10-K 28 Mar 2024
Q4 2022 $0 $0 31 Dec 2022 10-K 28 Mar 2024
Q4 2021 $0 $0 31 Dec 2021 10-K 23 Mar 2023
Q4 2020 $0 $0 31 Dec 2020 10-K 30 Mar 2022
Q4 2019 $0 $0 31 Dec 2019 10-K 01 Mar 2021
Q4 2018 $0 $0 31 Dec 2018 10-K 20 Feb 2020
Q4 2017 $0 $0 31 Dec 2017 10-K 12 Mar 2019
Q4 2016 $0 31 Dec 2016 10-K 12 Mar 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.